Safety and Immunogenicity of Novel Adenovirus Type 26– and Modified Vaccinia Ankara–Vectored Ebola Vaccines | Zendy

Iain Milligan | Zendy; Malick M. Gibani | Zendy; Richard P. Sewell | Zendy; Elizabeth Clutterbuck | Zendy; Danielle Campbell | Zendy; Emma Plested | Zendy; Elizabeth Nuthall | Zendy; Merryn Voysey | Zendy; Laura Silva-Reyes | Zendy; M. Juliana McElrath | Zendy; Stephen C. De Rosa | Zendy; Nicole Frahm | Zendy; Kristen W. Cohen | Zendy; Georgi Shukarev | Zendy; Nicola Orzabal | Zendy; Wilbert van Duijnhoven | Zendy; Carla Truyers | Zendy; Nora Bachmayer | Zendy; Daniel Splinter | Zendy; Nathaly Samy | Zendy; Maria Grazia Pau | Zendy; Hanneke Schuitemaker | Zendy; Kerstin Lühn | Zendy; Benoît Callendret | Zendy; Johan Van Hoof | Zendy; Macaya Douoguih | Zendy; Katie Ewer | Zendy; Brian Angus | Zendy; Andrew J. Pollard | Zendy; Matthew D. Snape | Zendy

AI Assistant Blog Pricing

Home ZAIA Blog

Open Access

Safety and Immunogenicity of Novel Adenovirus Type 26– and Modified Vaccinia Ankara–Vectored Ebola Vaccines

Author(s) -

Iain Milligan,

Malick M. Gibani,

Richard P. Sewell,

Elizabeth Clutterbuck,

Danielle Campbell,

Emma Plested,

Elizabeth Nuthall,

Merryn Voysey,

Laura Silva-Reyes,

M. Juliana McElrath,

Stephen C. De Rosa,

Nicole Frahm,

Kristen W. Cohen,

Georgi Shukarev,

Nicola Orzabal,

Wilbert van Duijnhoven,

Carla Truyers,

Nora Bachmayer,

Daniel Splinter,

Nathaly Samy,

Maria Grazia Pau,

Hanneke Schuitemaker,

Kerstin Lühn,

Benoît Callendret,

Johan Van Hoof,

Macaya Douoguih,

Katie Ewer,

Brian Angus,

Andrew J. Pollard,

Matthew D. Snape

Publication year - 2016

Publication title -

jama

Language(s) - English

Resource type - Journals

SCImago Journal Rank - 4.688

H-Index - 680

eISSN - 1538-3598

pISSN - 0098-7484

DOI - 10.1001/jama.2016.4218

Subject(s) - medicine , ebola vaccine , vaccinia , ebola virus , immunogenicity , adverse effect , virology , vaccination , modified vaccinia ankara , tolerability , immunization , randomized controlled trial , placebo , immunology , virus , antibody , biochemistry , alternative medicine , pathology , gene , recombinant dna , chemistry

Developing effective vaccines against Ebola virus is a global priority.

The content you want is available to Zendy users.

Already have an account? Click here to sign in.

Having issues? You can contact us here

Accelerating Research